ADD ANI AS A TRUSTED SOURCE
Add ANI as a Trusted Source for Reliable Information
Menu
Tirzepatide tops semaglutide in trial
Eli Lilly and Company announced on Monday detailed results from SURMOUNT-5, a phase 3b open-label clinical trial,...
Eli Lilly launches Mounjaro in India for obesity, Type-2 diabetes
Approved by the Central Drugs Standard Control Organization (CDSCO), Mounjaro® is available in single-dose...
Home
About Us
Our Products
Advertise
Contact Us
Terms & Condition
Privacy Policy
Copyright © aninews.in | All Rights Reserved.
Copyright © aninews.in | All Rights Reserved.